{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:04:44Z","timestamp":1784372684653,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaip.2017.06.008","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T15:16:33Z","timestamp":1500477393000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Comorbidities in Difficult-to-Control Asthma"],"prefix":"10.1016","volume":"6","author":[{"given":"Pieter-Paul","family":"Hekking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Amelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier R.","family":"Wener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth H.","family":"Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.06.008_bib1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/thx.2010.153643","article-title":"Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)","volume":"66","author":"Bel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.06.008_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.13-1619","article-title":"The preventable burden of productivity loss due to suboptimal asthma control: a population-based study","volume":"145","author":"Sadatsafavi","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.06.008_bib5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1183\/09031936.00141614","article-title":"Interaction effect of psychological distress and asthma control on productivity loss?","volume":"45","author":"Moullec","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338998","article-title":"The cost of persistent asthma in Europe: an international population-based study in adults","volume":"160","author":"Accordini","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaip.2015.08.003","article-title":"Utilization and costs of severe uncontrolled asthma in a managed-care setting","volume":"4","author":"Zeiger","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.008_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/02770903.2014.956894","article-title":"Assessing asthma control and associated risk factors among persons with current asthma\u2014findings from the child and adult Asthma Call-back Survey","volume":"52","author":"Zahran","year":"2015","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2017.06.008_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.05.00037905","article-title":"Risk factors of frequent exacerbations in difficult-to-treat asthma","volume":"26","author":"ten Brinke","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1710-1492-2-3-109","article-title":"The difficult-to-control asthmatic: a systematic approach","volume":"2","author":"Le","year":"2006","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.200904-0625OC","article-title":"Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity","volume":"180","author":"DiMango","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1442-2050.2012.01399.x","article-title":"Association of gastroesophageal reflux disease with asthma control","volume":"26","author":"Liang","year":"2013","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2017.06.008_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2008.06.024","article-title":"The relationship between obesity and asthma severity and control in adults","volume":"122","author":"Mosen","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4187\/respcare.02202","article-title":"Obesity and asthma: impact on severity, asthma control, and response to therapy","volume":"58","author":"Juel","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.jaip.2017.06.008_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaci.2012.04.014","article-title":"Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study","volume":"130","author":"Chipps","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2009.08.005","article-title":"Close correlation between anxiety, depression, and asthma control","volume":"104","author":"Di Marco","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/02770903.2013.810750","article-title":"Depressive symptomatology, quality of life and disease control among individuals with well-characterized severe asthma","volume":"50","author":"Yonas","year":"2013","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2017.06.008_bib19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1378\/chest.103.6.1662","article-title":"Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol","volume":"103","author":"Irwin","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.06.008_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.03.00017003","article-title":"Systematic assessment of difficult-to-treat asthma","volume":"22","author":"Robinson","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"Identifying \u2018well-controlled\u2019 and \u2018not well-controlled\u2019 asthma using the Asthma Control Questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.rmed.2014.10.007","article-title":"Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)","volume":"108","author":"Schleich","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jaci.2010.08.049","article-title":"Racial differences in biologic predictors of severe asthma: data from the Severe Asthma Research Program","volume":"126","author":"Gamble","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/thx.2010.137414","article-title":"Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry","volume":"65","author":"Heaney","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.06.008_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201107-1317PP","article-title":"Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program","volume":"185","author":"Jarjour","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.rmed.2016.01.009","article-title":"The epidemiology of asthma and its comorbidities in Poland\u2014health problems of patients with severe asthma as evidenced in the Province of Lodz","volume":"112","author":"Panek","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1164\/rccm.201502-0302OC","article-title":"Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen general population study. A prospective cohort study","volume":"192","author":"Colak","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2710.2008.00878.x","article-title":"Prevalence and determinants of pharmacy shopping behaviour","volume":"33","author":"Buurma","year":"2008","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jaip.2017.06.008_bib30","unstructured":"Global Initiative for Asthma. Diagnosis of Disease of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD overlap syndrome (ACOS). 2015. Available from: http:\/\/www.ginasthma.org\/. Accessed October 6, 2016."},{"key":"10.1016\/j.jaip.2017.06.008_bib31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2017.06.008_bib32","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaci.2012.12.1574","article-title":"Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma","volume":"131","author":"Thomson","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.00008615","article-title":"Asthma, COPD and overlap syndrome: a longitudinal study in young European adults","volume":"46","author":"de Marco","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2017.06.008_bib34","doi-asserted-by":"crossref","first-page":"e62985","DOI":"10.1371\/journal.pone.0062985","article-title":"The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population","volume":"8","author":"de Marco","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2017.06.008_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.07-2317","article-title":"Burden of concomitant asthma and COPD in a Medicaid population","volume":"134","author":"Shaya","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2017.06.008_bib36","unstructured":"Nationaal Kompas Volksgezondheid. Hoeveel Mensen Hebben \u00e9\u00e9n of Meer Chronische Ziekten? 2015. Available from: http:\/\/www.nationaalkompas.nl\/gezondheid-en-ziekte\/ziekten-en-aandoeningen\/chronische-ziekten-en-multimorbiditeit\/hoeveel-mensen-hebben-een-of-meer-chronische-ziekten\/. Accessed October 6, 2016."},{"key":"10.1016\/j.jaip.2017.06.008_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaci.2015.07.046","article-title":"Acute and chronic systemic corticosteroid-related complications in patients with severe asthma","volume":"136","author":"Lefebvre","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.008_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thoraxjnl-2015-207630","article-title":"Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry","volume":"71","author":"Sweeney","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2017.06.008_bib39","first-page":"833","article-title":"Dose-Response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma","volume":"22","author":"Dalal","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817304737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817304737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:01Z","timestamp":1761974101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817304737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213219817304737"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.06.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities in Difficult-to-Control Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}